Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation

Affiliations

¹ Second Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Hematology and Bone Marrow Transplantation, Evangelismos General Hospital, Athens, Greece.
³ Department of Bone Marrow Transplantation, Aghia Sophia Children Hospital, Athens, Greece.
⁴ Department of Clinical Microbiology, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
⁵ Forth Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
⁶ Second Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece. panagtsirigotis@gmail.com.

Maria Stamouli et al. Bone Marrow Transplant. 2021 Feb.

. 2021 Feb;56(2):511-513.

doi: 10.1038/s41409-020-01022-x. Epub 2020 Aug 8.

¹ Second Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Hematology and Bone Marrow Transplantation, Evangelismos General Hospital, Athens, Greece.
³ Department of Bone Marrow Transplantation, Aghia Sophia Children Hospital, Athens, Greece.
⁴ Department of Clinical Microbiology, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
⁵ Forth Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
⁶ Second Department of Internal Medicine, ATTIKO General University Hospital, National and Kapodistrian University of Athens, Athens, Greece. panagtsirigotis@gmail.com.

No abstract available

References

1. Martino R, Porras RP, Rabella N, Williams JV, Rámila E, Margall N, et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transpl. 2005;11:781–96. - DOI
1. Shah DP, Ghantoji SS, Ariza-Heredia E, Shah JN, El Taoum K, Shah PK, et al. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood. 2014;123:3263–8. - DOI
1. Seo S, Campbell A, Xie H, Chien J, Leisenring W, Englund J, et al. Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement. Biol Blood Marrow Transpl. 2013;19:589–96. - DOI
1. Shah D, Ghantoji SS, Shah JN, El Taoum K, Jiang Y, Popat U, et al. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother. 2013;68:1872–80. - DOI